Filtered By:
Management: Government
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 334 results found since Jan 2013.
Cambridge biotech delivers coronavirus vaccine
Government researchers are set to begin testing the first potential coronavirus vaccine, thanks to an emerging Cambridge biotech.
Moderna Inc. (Nasdaq: MRNA) reported after markets closed Monday it has delivered the first batch of its vaccine for COVID-19 over to a branch of the National Institutes of Health for clinical testing. The NIH's allergy and infectious disease institute will lead the next leg of development thr ough a collaboration between it and Moderna.
The Cambridge startup is…
Source: bizjournals.com Health Care:Biotechnology headlines - February 25, 2020 Category: Biotechnology Authors: Allison DeAngelis Source Type: news
Not His First Epidemic: Dr. Anthony Fauci Sticks to the Facts
Where politicians fumble and other government health officials step back, he steps up to explain.
Source: NYT - March 9, 2020 Category: American Health Authors: Denise Grady Tags: Coronavirus (2019-nCoV) United States Politics and Government Science and Technology Epidemics Research National Institute of Allergy and Infectious Diseases National Institutes of Health Fauci, Anthony S your-feed-healthcare Source Type: news
Why Wearing a Face Mask Is Encouraged in Asia, but Shunned in the U.S.
Cheryl Man is usually the only one wearing a face mask on her New York City subway train. She notices this, but other people on the train notice, too. Usually she just gets odd stares from other commuters. But on Tuesday morning, when she was walking to school, a group of teens jeered at her and coughed in her direction.
“I felt very humiliated and misunderstood,” says Man, a 20-year-old student and research assistant who is ethnically Chinese.
Man also feels the stigma at her workplace, where she keeps her mask on. None of her colleagues wear a face mask, and some of them have asked her if she is sick.
̶...
Source: TIME: Health - March 12, 2020 Category: Consumer Health News Authors: Hillary Leung / Hong Kong Tags: Uncategorized COVID-19 onetime overnight Source Type: news
China ’s Draconian Lockdown Is Getting Credit for Slowing Coronavirus. Would It Work Anywhere Else?
As COVID-19 spread rapidly across China, authorities took an aggressive stance to fight the coronavirus. They were slow to respond to the outbreak—at first suppressing information and denying that it could spread between humans even as it did just that. But, as case numbers skyrocketed, Beijing went to extraordinary lengths to fight the virus, identified at COVID-19, in a campaign Chinese President Xi Jinping has described as a “people’s war.”
The most dramatic, and controversial, of the measures was the lockdown of of tens of millions of people in what is believed to be the largest quasi-quarantin...
Source: TIME: Health - March 13, 2020 Category: Consumer Health News Authors: Amy Gunia Tags: Uncategorized COVID-19 overnight Source Type: news
Trump Is Tested for Coronavirus, and Experts Ask: What Took So Long?
Federal officials are asking Americans for extraordinary vigilance against a new pathogen. President Trump has taken a different course, worrying scientists.
Source: NYT Health - March 14, 2020 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: Quarantines United States Politics and Government Coronavirus (2019-nCoV) Tests (Medical) Ethics and Official Misconduct Mar-a-Lago (Palm Beach, Fla) National Institute of Allergy and Infectious Diseases Bolsonaro, Jair (1955- ) Caplan, Ar Source Type: news
New AIBS Report on Biological Sciences in the President ' s FY 2021 Budget
A new report from the American Institute of Biological Sciences (AIBS) provides an analysis of the President’s fiscal year (FY) 2021 budget request for biological sciences research and education.
The report provides an overview and analysis of the budget request for several federal agencies and programs, including the National Science Foundation, National Institutes of Health (NIH), National Institute of Standards and Technology, United States Geological Survey, Department of Energy Office of Science, National Oceanic and Atmospheric Administration, and Environmental Protection Agency, among others.
Most federal s...
Source: Public Policy Reports - March 17, 2020 Category: Biology Authors: AIBS Source Type: news
What the U.S. Needs to do Today to Follow South Korea ’s Model for Fighting Coronavirus
The United States has a narrow window of opportunity to determine the fate of its coronavirus crisis. Will we end up looking like Italy or South Korea?
Italy’s health system has imploded under the strain of new cases and the shortage of ventilators means doctors must make agonizing decisions on who to save and who to let die. In contrast, South Korea acted swiftly and boldly to “flatten the curve”— the government did everything it could to slow the rate of increase and so reduce the burden of the illness on the country’s clinics and hospitals.
Right now, the number of new cases of confirmed in...
Source: TIME: Health - March 17, 2020 Category: Consumer Health News Authors: Gavin Yamey Tags: Uncategorized COVID-19 Source Type: news
Trump ’s Embrace of Unproven Drugs to Treat Coronavirus Defies Science
Doctors and patients also worry that the president ’s rosy outlook for the treatments will exacerbate shortages of old malaria drugs relied on by patients with lupus and other debilitating conditions.
Source: NYT Health - March 21, 2020 Category: Consumer Health News Authors: Katie Thomas and Denise Grady Tags: Drugs (Pharmaceuticals) United States Politics and Government Coronavirus (2019-nCoV) Rheumatoid Arthritis Lupus Erythematosus Bayer AG Mylan Inc National Institute of Allergy and Infectious Diseases Fauci, Anthony S Trump, Donald J yo Source Type: news
First childhood flu helps explain why virus hits some people harder than others
Editor ’s note: This news release was updated March 3 to include a new link to the study about COVID-19 and to reflect that the study has been accepted by the journal eLife. The release was previously updated Feb. 5 to include new comments from Professor James Lloyd-Smith about screening practices use d by public health officials. Why are some people better able to fight off the flu than others? Part of the answer, according to a new study, is related to the first flu strain we encounter in childhood.Scientists from UCLA and the University of Arizona have found that people ’s ability to fight off the flu virus is d...
Source: UCLA Newsroom: Health Sciences - February 4, 2020 Category: Universities & Medical Training Source Type: news
Drug Eyed As Potential Coronavirus Treatment Being Hoarded, Leaving Patients In Need Without
BOSTON (CBS) – A drug that President Donald Trump has touted as a possible treatment for coronavirus is now in short supply. While the FDA has not yet approved hydroxychloroquine for COVID-19, some people are hoarding it, leaving patients who regularly rely on the medication scrambling.
“It would be a gift from God if that worked. It would be a big game changer,” Trump said of the anti-malarial drug.
Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease, and a prominent member of the White House Coronavirus Task Force has cautioned that evidence of its effectiveness in treating c...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 24, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Coronavirus Source Type: news
NIDCR's Spring 2020 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Spring 2020 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities
NIH/HHS News
Funding Notices
Science Advances
Subscribe to NICDR News
Grantee News
NIDCR News
CDC’s COVID-19 Guidance for Dental Settings
Dental health care personnel can find COVID-19-related information on the CDC’s Division of Oral Health website, which offers guidance and resources for clinics and health care facilities and recommendations for respondi...
Source: NIDCR Science News - March 27, 2020 Category: Dentistry Source Type: news
Medical Expert Who Corrects Trump Is Now a Target of the Far Right
Dr. Anthony Fauci, the administration ’s most outspoken advocate of emergency virus measures, faces a torrent of false claims that he is mobilizing to undermine the president.
Source: NYT Health - March 28, 2020 Category: Consumer Health News Authors: Davey Alba and Sheera Frenkel Tags: Rumors and Misinformation United States Politics and Government Social Media Coronavirus (2019-nCoV) Fringe Groups and Movements Facebook Inc Instagram Inc Judicial Watch National Institute of Allergy and Infectious Diseases Twitter Yo Source Type: news
C.D.C. Weighs Advising Everyone to Wear a Mask
Widespread use of nonmedical masks could reduce community transmission. But recommending their broad use could also cause a run on the kind of masks that health care workers desperately need.
Source: NYT Health - March 31, 2020 Category: Consumer Health News Authors: Abby Goodnough and Knvul Sheikh Tags: Masks Protective Clothing and Gear Shortages Coronavirus (2019-nCoV) Health Insurance and Managed Care United States Politics and Government Centers for Disease Control and Prevention National Institute of Allergy and Infectious Diseases F Source Type: news
Should Healthy People Wear Masks to Prevent Coronavirus? The Answer May Be Changing
If you have no symptoms of the coronavirus, should you wear a mask? It’s one of the most-asked questions during this pandemic, and until recently, one of the most easily answered—if you follow the guidance of the U.S. Centers for Disease Control and Prevention. The CDC’s answer, up until April 3? No. According to its initial guidelines, outside of health care settings, face masks should only be worn by people who are sick or who are caring for someone who is sick (when the person who is sick can’t wear a mask). A mask helps capture some of an ill person’s cough particles that might otherwise s...
Source: TIME: Health - April 3, 2020 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized COVID-19 Source Type: news
North Carolina pharma RedHill to have second drug tested for potential Covid-19 treatment
With fresh data from existing trials treating Covid-19 patients in Italy and Israel, a Triangle drugmaker has announced a deal with the federal government to explore another drug as a treatment for U.S. patients.
Raleigh-based RedHill (NASDAQ: RDHL) has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) — part of the National Institutes of Health (NIH) — to use its drug for non-clinical tests to treat Covid-19.
The drug, RHB-107, is believed…
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2020 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news
